Biosafety

September, 2005

Favre D, Viret JF. Biosafety evaluation of recombinant live oral bacterial vaccines in the context of European regulation. Vaccine. 2005 Aug 19.

Kaiser J. Virology. Resurrected influenza virus yields secrets of deadly 1918 pandemic. Science. 2005;310(5745):28-9.

Lai MYY, Cheng PKC, Lim WWL. Survival of severe acute respiratory syndrome coronavirus. Clin Infect Dis. 2005 Oct 1;41(7):e67-71.

Leomil L, Pestana de Castro AF, Krause G, Schmidt H, Beutin L. Characterization of two major groups of diarrheagenic Escherichia coli O26 strains which are globally spread in human patients and domestic animals of different species. FEMS Microbiol Lett. 2005;249(2):335-42.

Biocontainment

Lemunier M, Francou C, Rousseaux S, Houot S, Dantigny P, Piveteau P, Guzzo J. Long-term survival of pathogenic and sanitation indicator bacteria in experimental biowaste composts. Appl Environ Microbiol. 2005;71(10):5779-86.

Nygren O, Gustavsson B, Eriksson R. A test method for assessment of spill and leakage from drug preparation systems. Ann Occup Hyg. 2005;Aug 26:1-8.

Biosecurity

Begier EM, Bartlett NL, Mshar PA, Johnson DG, Hadler JL, and Connecticut Bioterrorism Field Epidemiology Response Team. Gram-positive Rod Surveillance for Early Anthrax Detection. Emerg Infect Dis. 2005;11(9):1483-6.

Cosgrove SE, Perl TM, Song X, Sisson SD. Ability of physicians to diagnose and manage illness due to category A bioterrorism agents. Arch Intern Med. 2005;165(17):2002-6.

Fock R, Grünewald T, Biederbick W, Wirtz A, Gottschalk R. Management of bioterroristic attacks. [Management bioterroristischer Anschläge mit gefährlichen infektiösen Agenzien] Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2005;48(9):1028-37.

Niska RW, Burt CW. Bioterrorism and mass casualty preparedness in hospitals: United States, 2003. Adv Data, Department of Health and Human Services, Centers for Disease Control and Prevention. 2005;(364):1-11.

Nordin JD, Goodman MJ, Kulldorf M, Ritzwoller DP, Abrams AM, Kleinman K, Levitt MJ, Donahue J, Platt R. Simulated anthrax attacks and syndromic surveillance. Emerg Infect Dis. 2005;11(9):1394-98.

Riedel S. Anthrax: a continuing concern in the era of bioterrorism. Proc (Bayl Univ Med Cent). 2005;18(3):234-43.

Riederer-Trainor C, Wilkinson T, Snook WD, Hoff GL, Griffin R, Archer R. When bioterrorism strikes: communication issues for the local health department. Health Promot Pract. 2005;6(4):424-9.

Williams T. Prepare for a major disaster: the laboratory and beyond. MLO Med Lab Obs. 2005;37(9):28, 30-1, 34, 36.

Disinfection/Decontamination

Adams D, Quayum M, Worthington T, Lambert P, Elliott T. Evaluation of a 2% chlorhexidine gluconate in 70% isopropyl alcohol skin disinfectant. J Hosp Infect. 2005 Oct 9.

Canter DA. Addressing residual risk issues at anthrax cleanups: how clean is safe? J Toxicol Environ Health Part A. 2005;68(11-12):1017-32.

Giacomelli LRB, Helbel C, Ogassawara RLN, Barreto AMW, Martins FM, Cardoso CL, Leite CQF. Improved laboratory safety by decontamination of unstained sputum smears for acid-fast microscopy. J Clin Microbiol. 2005;43(8):4245-8.

Kampf G, Kramer A. Efficacy of hand hygiene agents at short application times. Am J Infect Control. 2005;33(7):429-31.

Rutala WA, Weber DJ. The benefits of surface disinfection. Am J Infect Control. 2005;33(7):434-5.

Tortorano AM, Viviani MA, Biraghi E, Rigoni AL, Prigitano A, Grillot R; EBGA Network. In vitro testing of fungicidal activity of biocides against Aspergillus fumigatus. J Med Microbiol. 2005;54(Pt 10):955-7.

Laboratory-acquired Infections

Djeriri K, Charof R, Laurichesse H, Fontana L, El Aouad R, Merle JL, Catilina P, Beytout J, Chamoux A. Occupational risk for blood exposure and staff behaviour: a cross-sectional study in 3 Moroccan healthcare centers. Med Mal Infect. 2005;35(7-8):396-401.

Sejvar JJ, Johnson D, Popovic T, Miller JM, Downes F, Somsel P, Weyant R, Stephens DS, Perkins BA, Rosenstein NE. Assessing the risk of laboratory-acquired meningococcal disease. J Clin Microbiol. 2005;43(9):4811-4.

Shah SM, Bonauto D, Silverstein B, Foley M. Workers' compensation claims for needlestick injuries among healthcare workers in Washington State, 1996-2000. Infect Control Hosp Epidemiol. 2005;26(9):775-81.

Yagupsky P, Baron EJ. Laboratory exposures to brucellae and implications for bioterrorism. Emerg Infect Dis. 2005;11(8):1180-5.

Regulatory Initiatives

Abubakar I, Chalkley D, McEvoy M, Stanley N, Alshafi K. Evaluating compliance with national guidelines for the clinical, laboratory and public health management of tuberculosis in a low-prevalence English district. Public Health. 2005 Oct 31.

Bouza E, Sánchez-Carrillo C, Hernangómez S, González MJ. Laboratory-acquired brucellosis: a Spanish national survey. The Spanish Co-operative Group for the Study of Laboratory-acquired Brucellosis. J Hosp Infect. 2005;61(1):80-83.

Bradley CA, Rolka H, Walker D, Loonsk J. BioSense: implementation of a National Early Event Detection and Situational Awareness System. MMWR Morb Mortal Wkly Rep. 2005;54 Suppl:11-9.

Creedon SA. Healthcare workers' hand decontamination practices: compliance with recommended guidelines. J Adv Nurs. 2005;51(3):208-16.

Transportation of Dangerous Goods

© 2005 Public Health Agency of Canada

[Office of Laboratory Security] [Quarterly Biosafety Listings]